table of content
1 Study Coverage
1.1 Orphan Drugs Product Introduction
1.2 Global Orphan Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Orphan Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Orphan Drugs Sales in Volume for the Year 2017-2028
1.3 United States Orphan Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Orphan Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Orphan Drugs Sales in Volume for the Year 2017-2028
1.4 Orphan Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Orphan Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Orphan Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Orphan Drugs Market Dynamics
1.5.1 Orphan Drugs Industry Trends
1.5.2 Orphan Drugs Market Drivers
1.5.3 Orphan Drugs Market Challenges
1.5.4 Orphan Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Orphan Drugs Market Segment by Type
2.1.1 Oncology
2.1.2 Gastrointestinal
2.1.3 Pulmonary
2.1.4 Neurology
2.1.5 Hematology
2.1.6 Cardio-vascular
2.1.7 Metabolic Disorders
2.1.8 Endocrinology
2.1.9 Infectious Diseases
2.1.10 Others
2.2 Global Orphan Drugs Market Size by Type
2.2.1 Global Orphan Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Orphan Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Orphan Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Orphan Drugs Market Size by Type
2.3.1 United States Orphan Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Orphan Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Orphan Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Orphan Drugs Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail pharmacies
3.1.3 Others
3.2 Global Orphan Drugs Market Size by Application
3.2.1 Global Orphan Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Orphan Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Orphan Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Orphan Drugs Market Size by Application
3.3.1 United States Orphan Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Orphan Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Orphan Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Orphan Drugs Competitor Landscape by Company
4.1 Global Orphan Drugs Market Size by Company
4.1.1 Top Global Orphan Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Orphan Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Orphan Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Orphan Drugs Price by Manufacturer (2017-2022)
4.2 Global Orphan Drugs Concentration Ratio (CR)
4.2.1 Orphan Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Orphan Drugs in 2021
4.2.3 Global Orphan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Orphan Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Orphan Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Orphan Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Orphan Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Orphan Drugs Market Size by Company
4.5.1 Top Orphan Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Orphan Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Orphan Drugs Sales by Players (2020, 2021 & 2022)
5 Global Orphan Drugs Market Size by Region
5.1 Global Orphan Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Orphan Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Orphan Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Orphan Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Orphan Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Orphan Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Orphan Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Orphan Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Orphan Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Orphan Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Orphan Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Orphan Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Orphan Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Orphan Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Orphan Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Orphan Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Orphan Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Corporation Information
7.1.2 Novartis Description and Business Overview
7.1.3 Novartis Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Novartis Orphan Drugs Products Offered
7.1.5 Novartis Recent Development
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporation Information
7.2.2 Bristol-Myers Squibb Company Description and Business Overview
7.2.3 Bristol-Myers Squibb Company Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Bristol-Myers Squibb Company Orphan Drugs Products Offered
7.2.5 Bristol-Myers Squibb Company Recent Development
7.3 Celgene
7.3.1 Celgene Corporation Information
7.3.2 Celgene Description and Business Overview
7.3.3 Celgene Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Celgene Orphan Drugs Products Offered
7.3.5 Celgene Recent Development
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Corporation Information
7.4.2 F. Hoffmann-La Roche Description and Business Overview
7.4.3 F. Hoffmann-La Roche Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 F. Hoffmann-La Roche Orphan Drugs Products Offered
7.4.5 F. Hoffmann-La Roche Recent Development
7.5 Pfizer
7.5.1 Pfizer Corporation Information
7.5.2 Pfizer Description and Business Overview
7.5.3 Pfizer Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Pfizer Orphan Drugs Products Offered
7.5.5 Pfizer Recent Development
7.6 Sanofi
7.6.1 Sanofi Corporation Information
7.6.2 Sanofi Description and Business Overview
7.6.3 Sanofi Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Sanofi Orphan Drugs Products Offered
7.6.5 Sanofi Recent Development
7.7 Alexion Pharmaceuticals
7.7.1 Alexion Pharmaceuticals Corporation Information
7.7.2 Alexion Pharmaceuticals Description and Business Overview
7.7.3 Alexion Pharmaceuticals Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Alexion Pharmaceuticals Orphan Drugs Products Offered
7.7.5 Alexion Pharmaceuticals Recent Development
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Corporation Information
7.8.2 Eli Lilly and Company Description and Business Overview
7.8.3 Eli Lilly and Company Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Eli Lilly and Company Orphan Drugs Products Offered
7.8.5 Eli Lilly and Company Recent Development
7.9 Novo Nordisk
7.9.1 Novo Nordisk Corporation Information
7.9.2 Novo Nordisk Description and Business Overview
7.9.3 Novo Nordisk Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Novo Nordisk Orphan Drugs Products Offered
7.9.5 Novo Nordisk Recent Development
7.10 AstraZeneca
7.10.1 AstraZeneca Corporation Information
7.10.2 AstraZeneca Description and Business Overview
7.10.3 AstraZeneca Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 AstraZeneca Orphan Drugs Products Offered
7.10.5 AstraZeneca Recent Development
7.11 Eisai
7.11.1 Eisai Corporation Information
7.11.2 Eisai Description and Business Overview
7.11.3 Eisai Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Eisai Orphan Drugs Products Offered
7.11.5 Eisai Recent Development
7.12 Daiichi Sankyo Company
7.12.1 Daiichi Sankyo Company Corporation Information
7.12.2 Daiichi Sankyo Company Description and Business Overview
7.12.3 Daiichi Sankyo Company Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Daiichi Sankyo Company Products Offered
7.12.5 Daiichi Sankyo Company Recent Development
7.13 Bayer
7.13.1 Bayer Corporation Information
7.13.2 Bayer Description and Business Overview
7.13.3 Bayer Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Bayer Products Offered
7.13.5 Bayer Recent Development
7.14 GlaxoSmithKline
7.14.1 GlaxoSmithKline Corporation Information
7.14.2 GlaxoSmithKline Description and Business Overview
7.14.3 GlaxoSmithKline Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 GlaxoSmithKline Products Offered
7.14.5 GlaxoSmithKline Recent Development
7.15 Merck & Co
7.15.1 Merck & Co Corporation Information
7.15.2 Merck & Co Description and Business Overview
7.15.3 Merck & Co Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Merck & Co Products Offered
7.15.5 Merck & Co Recent Development
7.16 Johnson & Johnson
7.16.1 Johnson & Johnson Corporation Information
7.16.2 Johnson & Johnson Description and Business Overview
7.16.3 Johnson & Johnson Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Johnson & Johnson Products Offered
7.16.5 Johnson & Johnson Recent Development
7.17 Biogen
7.17.1 Biogen Corporation Information
7.17.2 Biogen Description and Business Overview
7.17.3 Biogen Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Biogen Products Offered
7.17.5 Biogen Recent Development
7.18 Takeda
7.18.1 Takeda Corporation Information
7.18.2 Takeda Description and Business Overview
7.18.3 Takeda Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Takeda Products Offered
7.18.5 Takeda Recent Development
7.19 Amgen
7.19.1 Amgen Corporation Information
7.19.2 Amgen Description and Business Overview
7.19.3 Amgen Orphan Drugs Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Amgen Products Offered
7.19.5 Amgen Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Orphan Drugs Industry Chain Analysis
8.2 Orphan Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Orphan Drugs Distributors
8.3 Orphan Drugs Production Mode & Process
8.4 Orphan Drugs Sales and Marketing
8.4.1 Orphan Drugs Sales Channels
8.4.2 Orphan Drugs Distributors
8.5 Orphan Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
